↓ Skip to main content

Dove Medical Press

Article Metrics

Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
57 Mendeley
Title
Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire Thai version
Published in
Neuropsychiatric Disease and Treatment, August 2014
DOI 10.2147/ndt.s67842
Pubmed ID
Authors

Pichai Ittasakul, Punjaporn Waleeprakhon, Manote Lotrakul, Pattarabhorn Wisajun, Sudawan Jullagate, Terence Ketter

Abstract

The Mood Disorder Questionnaire (MDQ) has been translated to many languages and has been used in many countries as a screening instrument for bipolar disorder. The main objective of this study was to evaluate validity of the Thai version of the MDQ as a screening instrument for bipolar disorder in a psychiatric outpatient sample, and to determine its optimum question #1 item threshold value for bipolar disorder.

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
United States 1 2%
Unknown 55 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 16%
Researcher 7 12%
Student > Doctoral Student 6 11%
Professor > Associate Professor 4 7%
Other 4 7%
Other 14 25%
Unknown 13 23%
Readers by discipline Count As %
Psychology 23 40%
Medicine and Dentistry 11 19%
Nursing and Health Professions 2 4%
Social Sciences 2 4%
Computer Science 1 2%
Other 5 9%
Unknown 13 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 September 2020.
All research outputs
#4,749,831
of 18,912,409 outputs
Outputs from Neuropsychiatric Disease and Treatment
#643
of 2,755 outputs
Outputs of similar age
#47,719
of 209,229 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#4
of 13 outputs
Altmetric has tracked 18,912,409 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 2,755 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 209,229 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.